Emory University Purchases Corning® Epic® System

Corning Incorporated (NYSE: GLW) today announced that Emory University purchased the label-free Corning® Epic® System to integrate into its extensive drug discovery program at the Emory Chemical Biology Discovery Center (ECBDC). This technology will enable ECBDC to further develop chemical tools for biological research and drive the discovery of new drug compounds which may lead to new therapeutics for disease.

ECBDC is part of the Molecular Libraries Screening Centers Network (MLSCN), which is funded by the National Institutes of Health (NIH). The MLSCN consists of 10 screening centers focused on discovering new chemical probes via a diverse set of screening platform technologies. It also serves Emory investigators, as well as off-campus collaborators, for their small molecule lead discovery needs.

“Emory’s decision to purchase the Corning Epic System highlights the significant potential of label-free technology in drug discovery,” said Ron Verkleeren, business director, Corning Epic System. “Epic’s ability to non-invasively monitor the real-time responses of small molecular compounds in living cells will provide Emory with valuable insights which could streamline their search for new drugs.”

The Corning Epic System is the world’s first high-throughput, label-free screening system. It is able to perform biochemical and cell-based assays without the addition of radioactive or fluorescent dyes, which may interfere with biochemical interactions. It uses patented optical biosensors technology to measure a broad range of biological responses that are undetectable with conventional methods.

For additional information on the Epic System or any other Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States, (+1) 978-635-2200 internationally, or visit www.corning.com/epic.

About Emory Chemical Biology Discovery Center

In a collaborative effort between the School of Medicine and the Department of Chemistry, the Emory Chemical Biology Discovery Center (ECBDC) was founded in 2003 by Drs. Haian Fu, Ray Dingledine, and Dennis Liotta. The missions of the ECBDC are to discover novel chemical leads targeted to disease-related proteins for research tools and therapies and to train the next generation of drug discovery scientists. The ECBDC has the capability to adapt and optimize all target-based assays, cell reporter assays and phenotypic assays and to carry out HTS and HCS in both 384- and 1536-well plate format. The center is equipped with two fully integrated robotic systems for HTS and HCS.

About Corning Incorporated

Corning Incorporated (www.corning.com) is the world leader in specialty glass and ceramics. Drawing on more than 150 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy and metrology.

Contacts:

Media Relations:
Michael Hallstrom, 607-974-0379
hallstrom@corning.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.